Revelation Biosciences, Inc. (REVB)
3.535
-0.26
(-6.73%)
USD |
NASDAQ |
Oct 26, 16:00
3.50
-0.04
(-0.99%)
After-Hours: 20:00
Revelation Biosciences Net Income (Quarterly) : -3.323M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.323M |
| March 31, 2026 | -3.009M |
| December 31, 2025 | -2.511M |
| September 30, 2025 | -1.907M |
| June 30, 2025 | -2.444M |
| March 31, 2025 | -2.051M |
| December 31, 2024 | -1.726M |
| September 30, 2024 | -2.242M |
| June 30, 2024 | -8.390M |
| March 31, 2024 | -2.681M |
| December 31, 2023 | -2.203M |
| September 30, 2023 | -2.628M |
| June 30, 2023 | -1.448M |
| March 31, 2023 | 6.159M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.208M |
| September 30, 2022 | -1.171M |
| June 30, 2022 | -1.835M |
| March 31, 2022 | -6.616M |
| December 31, 2021 | -3.860M |
| September 30, 2021 | -3.044M |
| June 30, 2021 | -2.470M |
| March 31, 2021 | -2.612M |
| December 31, 2020 | -1.622M |
| September 30, 2020 | -0.0009M |
| June 30, 2020 | -0.0005M |
| March 31, 2020 | -0.0072M |
| December 31, 2019 | -0.0036M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | -3.146M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Agenus, Inc. | -0.567M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Amgen, Inc. | 2.375B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.323M |
| EPS Diluted (Quarterly) | -6.075 |
| Enterprise Value | -8.769M |
| Earnings Yield | -2.44K% |
| Normalized Earnings Yield | -2435.45 |